the events to watch for in the coming year
Weight-loss wonder drugs Following the runaway success of ‘miracle’ drug Wegovy (semaglutide) and other GLP-1 agonists, 2025 is likely to bring results and approvals for a new wave of treatments targeting obesity. The pharmaceutical firm Eli Lilly in Indianapolis, Indiana, will wrap up a phase III trial for its oral pill orforglipron, evaluating its long-term … Read more